International randomized phase III study on the treatment of children and adolescents with refractory or relapsed acute myeloid leukemia: Pediatric Relapsed 2010/01

Trial Profile

International randomized phase III study on the treatment of children and adolescents with refractory or relapsed acute myeloid leukemia: Pediatric Relapsed 2010/01

Recruiting
Phase of Trial: Phase III

Latest Information Update: 26 Nov 2016

At a glance

  • Drugs Gemtuzumab ozogamicin (Primary)
  • Indications Acute myeloid leukaemia
  • Focus Therapeutic Use
  • Acronyms Pediatric Relapsed AML 2010/01
  • Most Recent Events

    • 11 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top